{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:15:05Z","timestamp":1778577305759,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008848","name":"Elite Network of Bavaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004350","name":"German National Merit Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-GM129325"],"award-info":[{"award-number":["R01-GM129325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["Gm 13\/13-1"],"award-info":[{"award-number":["Gm 13\/13-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007215","name":"Association of the Chemical Industry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007215","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bmc.2024.117823","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:53:25Z","timestamp":1719586405000},"page":"117823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Structure-guided discovery of orexin receptor-binding PET ligands"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3792-2868","authenticated-orcid":false,"given":"Katharina","family":"Distler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Maschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-1488","authenticated-orcid":false,"given":"Eduard","family":"Neu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-3313","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Einsiedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-3656","authenticated-orcid":false,"given":"Olaf","family":"Prante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gmeiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117823_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.12415","article-title":"The hypocretins\/orexins: integrators of multiple physiological functions","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2024.117823_b0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmc.2024.117823_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117823_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117823_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117823_b0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2024.117823_b0035","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.2174\/138161210793292483","article-title":"Orexins\/hypocretins: pain regulation and cellular actions","volume":"16","author":"Chiou","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2024.117823_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(00)00470-X","article-title":"Orexin-A, an hypothalamic peptide with analgesic properties","volume":"92","author":"Bingham","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.bmc.2024.117823_b0045","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/chem.201604633","article-title":"Alcohol-enhanced Cu-mediated radiofluorination","volume":"23","author":"Zischler","year":"2017","journal-title":"Chem - Eur J."},{"key":"10.1016\/j.bmc.2024.117823_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.812270","article-title":"PET Molecular imaging in drug development: the imaging and chemistry perspective","volume":"9","author":"Nerella","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.bmc.2024.117823_b0055","first-page":"208","article-title":"Use of molecular imaging in clinical drug development: a systematic review","volume":"2019","author":"Son","year":"2010","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmc.2024.117823_b0060","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.bmcl.2013.03.079","article-title":"Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0065","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.bmcl.2012.01.114","article-title":"Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors","volume":"22","author":"Liu","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acsmedchemlett.3c00320","article-title":"Development of Novel 11C-labeled selective orexin-2 receptor radioligands for positron emission tomography imaging","volume":"14","author":"Rong","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.nucmedbio.2013.07.001","article-title":"Evaluation of potential PET imaging probes for the orexin 2 receptors","volume":"40","author":"Wang","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2024.117823_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105779","article-title":"Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging","volume":"123","author":"Bai","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0085","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1039\/C9MD00397E","article-title":"Synthesis and characterization of a novel 18F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor","volume":"10","author":"Watanabe","year":"2019","journal-title":"MedChemComm."},{"key":"10.1016\/j.bmc.2024.117823_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/DDDT.S404992","article-title":"Synthesis and characterization of a new carbon-11 labeled positron emission tomography radiotracer for orexin 2 receptors neuroimaging","volume":"18","author":"Wang","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2024.117823_b0095","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.bmcl.2019.04.044","article-title":"Synthesis and biological evaluation of F-18 labeled tetrahydroisoquinoline derivatives targeting orexin 1 receptor","volume":"29","author":"Watanabe","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128098","article-title":"Synthesis and biological evaluation of novel 18F-labeled phenylbenzofuran-2-carboxamide derivative for detection of orexin 1 receptor in the brain","volume":"43","author":"Watanabe","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0105","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/molecules25051018","article-title":"A new positron emission tomography probe for orexin receptors neuroimaging","volume":"25","author":"Bai","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117823_b0110","doi-asserted-by":"crossref","first-page":"18059","DOI":"10.1073\/pnas.2002704117","article-title":"Structure-based development of a subtype-selective orexin 1 receptor antagonist","volume":"117","author":"Hellmann","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117823_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"Michelson","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bmc.2024.117823_b0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nsmb.3183","article-title":"Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors","volume":"23","author":"Yin","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmc.2024.117823_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature14035","article-title":"Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant","volume":"519","author":"Yin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117823_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR residue numbers \u2013 aligning topology maps while minding the gaps","volume":"36","author":"Isberg","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2024.117823_b0135","series-title":"Methods in Neurosciences","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","author":"Ballesteros","year":"1995"},{"key":"10.1016\/j.bmc.2024.117823_b0140","unstructured":"Schr\u00f6dinger, LLC, The PyMOL Molecular Graphics System, Version 1.8, 2015."},{"key":"10.1016\/j.bmc.2024.117823_b0145","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/acs.orglett.5b02269","article-title":"Photocatalytic dehydrogenative lactonization of 2-arylbenzoic acids","volume":"17","author":"Ramirez","year":"2015","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0150","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","article-title":"Promotion of sleep by suvorexant\u2014a novel dual orexin receptor antagonist","volume":"25","author":"Winrow","year":"2011","journal-title":"J Neurogenet"},{"key":"10.1016\/j.bmc.2024.117823_b0160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ph14090833","article-title":"18F-Fluorination using tri-Tert-butanol ammonium iodide as phase-transfer catalyst: an alternative minimalist approach","volume":"14","author":"Shinde","year":"2021","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bmc.2024.117823_b0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/jm991098z","article-title":"Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype","volume":"43","author":"H\u00fcbner","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0170","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1016\/S0021-9258(18)33497-5","article-title":"Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate","volume":"257","author":"Bolin","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1021\/bi0205449","article-title":"Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series","volume":"42","author":"Stoll","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117823_b0180","doi-asserted-by":"crossref","unstructured":"Klebe G. Wirkstoffdesign: Entwurf und Wirkung von Arzneistoffen. Berlin, Heidelberg, Germany: Springer Spektrum; 2023. doi: 10.1007\/978-3-662-67209-9.","DOI":"10.1007\/978-3-662-67209-9"},{"key":"10.1016\/j.bmc.2024.117823_b0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117823_b0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41593-021-00971-w","article-title":"Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties","volume":"25","author":"Chen","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmc.2024.117823_b0195","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acs.jmedchem.9b01787","article-title":"Comparison of orexin 1 and orexin 2 ligand binding modes using X-ray crystallography and computational analysis","volume":"63","author":"Rappas","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0200","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/cctc.201300470","article-title":"Palladium-catalyzed C-H ortho arylation of benzoic acids with diaryliodonium salts in water","volume":"5","author":"Wu","year":"2013","journal-title":"ChemCatChem"},{"key":"10.1016\/j.bmc.2024.117823_b0205","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1021\/acs.orglett.0c01208","article-title":"Remote and selective C(sp2)\u2013H olefination for sequential regioselective linkage of phenanthrenes","volume":"22","author":"Wei","year":"2020","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0215","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2024.117823_b0220","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmc.2024.117823_b0230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117823_b0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117823_b0240","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117823_b0245","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","article-title":"Lipid21: complex lipid membrane simulations with AMBER","volume":"18","author":"Dickson","year":"2022","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117823_b0250","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building water models: a different approach","volume":"5","author":"Izadi","year":"2014","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.bmc.2024.117823_b0255","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1021\/acs.jctc.3c00039","article-title":"Development and benchmarking of open force field 2.0.0: the sage small molecule force field","volume":"19","author":"Boothroyd","year":"2023","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2024.117823_b0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX."},{"key":"10.1016\/j.bmc.2024.117823_b0265","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117823_b0270","doi-asserted-by":"crossref","DOI":"10.1063\/5.0020514","article-title":"Pressure control using stochastic cell rescaling","volume":"153","author":"Bernetti","year":"2020","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117823_b0275","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0280","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2024.117823_b0285","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2024.117823_b0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graphics."},{"key":"10.1016\/j.bmc.2024.117823_b0295","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2024.117823_b0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"10.1016\/j.bmc.2024.117823_b0305","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J Open Source Softw."},{"key":"10.1016\/j.bmc.2024.117823_b0310","unstructured":"PhysChem, version 2023, Advanced Chemistry Development, Inc. (ACD\/Labs), Toronto, ON, Canada, www.acdlabs.com."},{"key":"10.1016\/j.bmc.2024.117823_b0315","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117823_b0320","unstructured":"Molinspiration Cheminformatics free web services, Slovensky Grob, Slovakia, https:\/\/www.molinspiration.com."},{"key":"10.1016\/j.bmc.2024.117823_b0325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Nerosci"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624002372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624002372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:31:08Z","timestamp":1778574668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624002372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":65,"alternative-id":["S0968089624002372"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117823","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-r63tb","asserted-by":"object"}]},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of orexin receptor-binding PET ligands","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117823"}}